Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$32.99
Market cap
$16.84B
P/E Ratio
157.1
Dividend/share
$1.16
EPS
$0.21
Enterprise value
$28.62B
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating
Highlights
Baxter International's debt has decreased by 22% YoY
The gross profit has grown by 10% year-on-year
The company's equity rose by 3% QoQ but it fell by 2.8% YoY
BAX's net income has dropped by 96% year-on-year and by 96% since the previous quarter
The EPS has plunged by 96% YoY and by 96% from the previous quarter
Key stats
What are the main financial stats of BAX
Market
Valuations
Earnings
Shares outstanding
510.59M
Market cap
$16.84B
Enterprise value
$28.62B
Price to earnings (P/E)
157.1
Price to book (P/B)
2.14
Price to sales (P/S)
1.2
EV/EBIT
38.94
EV/EBITDA
15.8
EV/Sales
2.05
Revenue
$13.99B
EBIT
$735M
EBITDA
$1.81B
Free cash flow
$549M
Per share
Balance sheet
Liquidity
EPS
$0.21
Free cash flow per share
$1.08
Book value per share
$15.43
Revenue per share
$27.43
TBVPS
$30.28
Total assets
$26.68B
Total liabilities
$18.73B
Debt
$13.19B
Equity
$7.87B
Working capital
$2.66B
Debt to equity
1.68
Current ratio
1.43
Quick ratio
0.51
Net debt/EBITDA
6.5
Margins
Efficiency
Dividend
EBITDA margin
12.9%
Gross margin
38.1%
Net margin
0.8%
Operating margin
3.4%
Return on assets
0.4%
Return on equity
1.3%
Return on invested capital
3.6%
Return on capital employed
3.6%
Return on sales
5.3%
Dividend yield
3.52%
DPS
$1.16
Payout ratio
552.4%
BAX stock price
How has the Baxter International stock price performed over time
Intraday
1.1%
1 week
4.07%
1 month
-9.79%
1 year
-7.59%
YTD
-14.67%
QTD
-13.12%
Financial performance
How have Baxter International's revenue and profit performed over time
Revenue
$13.99B
Gross profit
$5.32B
Operating income
$479M
Net income
$108M
Gross margin
38.1%
Net margin
0.8%
BAX's net income has dropped by 96% year-on-year and by 96% since the previous quarter
Baxter International's net margin has plunged by 96% YoY and by 96% from the previous quarter
The operating margin has decreased by 21% YoY and by 6% from the previous quarter
Baxter International's operating income has decreased by 18% YoY and by 4.8% from the previous quarter
Growth
What is Baxter International's growth rate over time
Valuation
What is Baxter International stock price valuation
P/E
157.1
P/B
2.14
P/S
1.2
EV/EBIT
38.94
EV/EBITDA
15.8
EV/Sales
2.05
The EPS has plunged by 96% YoY and by 96% from the previous quarter
BAX's P/B is 48% below its 5-year quarterly average of 4.1 and 11% below its last 4 quarters average of 2.4
The company's equity rose by 3% QoQ but it fell by 2.8% YoY
BAX's P/S is 54% below its 5-year quarterly average of 2.6 and 14% below its last 4 quarters average of 1.4
The revenue is up by 3.1% year-on-year
Efficiency
How efficient is Baxter International business performance
The company's return on equity has shrunk by 97% YoY and by 96% QoQ
The ROA has plunged by 96% YoY and by 95% from the previous quarter
The ROS has plunged by 77% YoY and by 77% from the previous quarter
The ROIC has plunged by 76% from the previous quarter and by 72% YoY
Dividends
What is BAX's dividend history
DPS
$1.16
Dividend yield
3.52%
Payout ratio
552.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Baxter International financials performed over time
The total assets is 42% more than the total liabilities
The quick ratio has dropped by 62% year-on-year and by 34% since the previous quarter
The current ratio fell by 26% YoY but it rose by 2.1% QoQ
Baxter International's debt is 68% more than its equity
Baxter International's debt has decreased by 22% YoY
The debt to equity has declined by 20% year-on-year and by 4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.